The latest price target for Moelis (NYSE:MC) was reported by Morgan Stanley on October 24, 2024. The analyst firm set a price target for $66.00 expecting MC to fall to within 12 months (a possible -10.06% downside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Moelis (NYSE:MC) was provided by Morgan Stanley, and Moelis maintained their underweight rating.

The last upgrade for Moelis & Co happened on March 13, 2024 when Goldman Sachs raised their price target to $58. Goldman Sachs previously had a sell for Moelis & Co.

The last downgrade for Moelis & Co happened on January 11, 2023 when Goldman Sachs changed their price target from $40 to $37 for Moelis & Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moelis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moelis was filed on October 24, 2024 so you should expect the next rating to be made available sometime around October 24, 2025.

While ratings are subjective and will change, the latest Moelis (MC) rating was a maintained with a price target of $67.00 to $66.00. The current price Moelis (MC) is trading at is $73.38, which is out of the analyst’s predicted range.